Cargando…

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment

Glycogen synthase kinase (GSK)3β is a multifunctional serine/threonine protein kinase with more than 100 substrates and interacting molecules. GSK3β is normally active in cells and negative regulation of GSK3β activity via phosphorylation of its serine 9 residue is required for most normal cells to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domoto, Takahiro, Uehara, Masahiro, Bolidong, Dilireba, Minamoto, Toshinari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349761/ https://www.ncbi.nlm.nih.gov/pubmed/32503133 http://dx.doi.org/10.3390/cells9061388

Ejemplares similares

Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer
por: Uehara, Masahiro, et al.
Publicado: (2020)

Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma
por: Bolidong, Dilireba, et al.
Publicado: (2020)

Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
por: Domoto, Takahiro, et al.
Publicado: (2016)

Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma
por: Abe, Kensaku, et al.
Publicado: (2019)

Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012)

Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promoter region (TPR)-dynein interaction
por: Dewi, Firli R.P., et al.
Publicado: (2018)

Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin
por: Shimozaki, Shingo, et al.
Publicado: (2016)

Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma
por: Furuta, Takuya, et al.
Publicado: (2017)

Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
por: Kitano, Ayako, et al.
Publicado: (2013)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer
por: Elmadbouh, Omer H. M., et al.
Publicado: (2022)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Glycogen synthase kinase 3β in Toll-like receptor signaling
por: Ko, Ryeojin, et al.
Publicado: (2016)

Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?
por: Koistinaho, Jari, et al.
Publicado: (2011)

Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis
por: Zheng, Hanxue, et al.
Publicado: (2020)

Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer
por: Yin, Yan, et al.
Publicado: (2013)

Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells
por: Santha, Sreevidya, et al.
Publicado: (2016)

Brief Review of the Role of Glycogen Synthase Kinase-3β in Amyotrophic Lateral Sclerosis
por: Koh, Seong-Ho, et al.
Publicado: (2011)

Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
por: LI, DA-WEI, et al.
Publicado: (2014)

Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD
por: Ngkelo, Anta, et al.
Publicado: (2015)

Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors
por: Hulcová, Daniela, et al.
Publicado: (2018)

Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases
por: Marosi, Mate, et al.
Publicado: (2022)

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer
por: Fu, Yunfeng, et al.
Publicado: (2014)

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
por: Pandey, Mukesh K., et al.
Publicado: (2016)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

Glycogen synthase kinase 3 beta: can it be a target for oral cancer
por: Mishra, Rajakishore
Publicado: (2010)

Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer
por: Chen, Shuo, et al.
Publicado: (2016)

Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
por: Jope, Richard Scott
Publicado: (2011)

Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment
por: Martinez, Ana, et al.
Publicado: (2011)

Expression of Glycogen synthase kinase 3-β (GSK3-β) gene in azoospermic men
por: Nazarian, Hamid, et al.
Publicado: (2014)

In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β)
por: Goyal, Shuchi, et al.
Publicado: (2023)

Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
por: Haq, Syed, et al.
Publicado: (2000)

Allosteric Regulation of Glycogen Synthase Kinase 3β: A Theoretical Study
por: Buch, Idit, et al.
Publicado: (2010)

Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma
por: Dionyssiou, M G, et al.
Publicado: (2014)

Glycogen synthase kinase 3β inhibition enhances Notch1 recycling
por: Zheng, Li, et al.
Publicado: (2018)

In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains
por: Krishnankutty, Ambika, et al.
Publicado: (2017)

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017)

Regulation of Autophagy by the Glycogen Synthase Kinase-3 (GSK-3) Signaling Pathway
por: Pan, Hsuan-Yeh, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of 3-Benzisoxazolyl-4-indolylmaleimides as Potent, Selective Inhibitors of Glycogen Synthase Kinase-3β
por: Ye, Qing, et al.
Publicado: (2013)

Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer
por: Ugolkov, Andrey V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_moeuahuo0libni0uams2hqtj7d